Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9051–9100 of 33127
each of the directors of the Company (Douglas Godshall, Kevin Ballinger, Laura Francis, C. Raymond Larkin, Jr., Frederic Moll, M.D., Antoine Papiernik, Maria Sainz, Sara Toyloy and F.T. “Jay” Watkins) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
the employment of Douglas Godshall, the Company’s President and Chief Executive Officer, and Renee Gaeta, the Company’s Chief Financial Officer, was terminated effective immediately prior to the consummation of the Merger.
each of the directors of the Company (Douglas Godshall, Kevin Ballinger, Laura Francis, C. Raymond Larkin, Jr., Frederic Moll, M.D., Antoine Papiernik, Maria Sainz, Sara Toyloy and F.T. “Jay” Watkins) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
the employment of Douglas Godshall, the Company’s President and Chief Executive Officer, and Renee Gaeta, the Company’s Chief Financial Officer, was terminated effective immediately prior to the consummation of the Merger.
each of the directors of the Company (Douglas Godshall, Kevin Ballinger, Laura Francis, C. Raymond Larkin, Jr., Frederic Moll, M.D., Antoine Papiernik, Maria Sainz, Sara Toyloy and F.T. “Jay” Watkins) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
each of the directors of the Company (Douglas Godshall, Kevin Ballinger, Laura Francis, C. Raymond Larkin, Jr., Frederic Moll, M.D., Antoine Papiernik, Maria Sainz, Sara Toyloy and F.T. “Jay” Watkins) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
each of the directors of the Company (Douglas Godshall, Kevin Ballinger, Laura Francis, C. Raymond Larkin, Jr., Frederic Moll, M.D., Antoine Papiernik, Maria Sainz, Sara Toyloy and F.T. “Jay” Watkins) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
each of the directors of the Company (Douglas Godshall, Kevin Ballinger, Laura Francis, C. Raymond Larkin, Jr., Frederic Moll, M.D., Antoine Papiernik, Maria Sainz, Sara Toyloy and F.T. “Jay” Watkins) resigned and ceased to be directors of the Company and members of any committee of the Company’s board of directors.
On May 31, 2024, Yaron Valler informed the Company of his decision to resign as Chief Investment Officer of the Company, effective immediately.
On May 31, 2024, Shmuel Chafets informed Target Global Acquisition I Corp. (the “Company”) of his decision to resign as Chief Executive Officer (“CEO”) of the Company, effective immediately.
On May 31, 2024, Catherine Sohn, Pharm.D. notified the board of directors (the “Board”) of Jazz Pharmaceuticals plc (the “Company”), that she is retiring and will not stand for re-election to the Board, when her term expires, at the Company’s 2024 annual general meeting of shareholders.
On May 29, 2024, Ashley Levesque advised Banzai International, Inc. of her decision to resign from her position as Vice President of Marketing.
On May 30, 2024, Edward J. Dulac III provided notice of his resignation from his position as Chief Financial Officer of Fate Therapeutics, Inc. (the “Company”), which will be effective June 14, 2024.
Dr. Heinrich’s decision to resign
On May 31, 2024, Anthony R. Corpora stepped down as the chief executive officer and a board member of US Lighting Group, Inc.
On May 24, 2024, Derek Campbell and Brian Ferrier resigned from the Board of Directors of Nukkleus Inc. (the “Company”), effective immediately.
On May 24, 2024, Derek Campbell and Brian Ferrier resigned from the Board of Directors of Nukkleus Inc. (the “Company”), effective immediately.
On May 28, 2024, Kevin Mullins, who served as a member of the board of directors (the “Board”) of Wrap Technologies, Inc. (the “Company”), tendered his resignation from his role as director of the Company, effective as of May 28, 2024.
On May 28, 2024, Mr. Steve Richie notified Laird Superfood, Inc. (the “Company”) of his intention to retire as General Counsel and Secretary of the Company, effective as of a date that is mutually agreeable between Mr. Richie and the Company, currently anticipated to be no sooner than June 7, 2024 (the “Effective Date”).
Effective May 28, 2024, Gregory Lambrecht resigned as the Chief Executive Officer, Chief Financial Officer, and Chairman of the Board of 1606 Corp., a Nevada corporation (the “ Company ”).
Effective as of May 20, 2024, Liu Yang voluntarily resigned as a Member of the Board of Directors of China Foods Holdings Limited.
Effective as of May 20, 2024, Chen Ni Hu voluntarily resigned as a Member of the Board of Directors of China Foods Holdings Limited.
notified the Company of its removal, without cause, of Antonio Ursano Jr. as its shareholder director on the Board of the Company and its appointment of Bradley E. Cooper to the Board, each effective June 1, 2024.
On May 31, 2024, McAndrew Rudisill, Chief Investment Officer and a director of the Company, notified the Company of his decision to resign from his position as Chief Investment Officer and from the Board, effective immediately.
Also on May 31, 2024, Todd Hirsch, a director of the Company, notified the Company of his decision to resign from the Board, effective immediately.
On May 30, 2024, Brian Pratt gave the Board of Directors (the “Board”) of Southland Holdings, Inc. (“Southland”) notice of his resignation as Chairman of the Board and Director of Southland.
On May 31, 2024, David J. Lee notified Benson Hill, Inc. (the “Company”) of his decision not to stand for re-election to the Board of Directors of the Company (the “Board”) at the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).
On May 28, 2024, Mohammed (Rally) G. Zerhouni, Senior Vice President of Finance, Principal Accounting Officer of SJW Group (the “Company”), and of San Jose Water Company, SJWTX, Inc., SJWTX Holdings, Inc., and Connecticut Water Service, Inc., all wholly-owned subsidiaries of the Company, notified the Company of his intent to resign from the Company and its subsidiaries, effective June 14, 2024, in order to pursue another opportunity.
On May 28, 2024, Omega Therapeutics, Inc. (the “Company”) and Yan Moore, M.D., the Company’s Chief Medical Officer, agreed to terminate his employment effective as of May 31, 2024.
Effective as of the closing of the Transaction, Mr. David C. Elder will resign from his position as Vice President, Strategic Initiatives, Business Optimization & Chief Accounting Officer and cease to serve in such roles with the Company.
On May 27, 2024, John Miller, the President of Tobacco for 22 nd Century Group, Inc. (the “Compay”), provided notice that he is resigning from such position effective August 2, 2024.
On May 28, 2024, Brent Billinger, Senior Vice President and Controller of Sanmina Corporation (the “Company”) notified the Company of his plan to retire, effective January 3, 2025.
Tony Satterthwaite, the Company’s Senior Vice President, will retire from the Company, effective September 15, 2024.
each of Mark P. Lappe, Douglas G. Forsyth, Jon Faiz Kayyem, Kimberly Manhard and Kristiina Vuori resigned from the board of directors of the Company.
each of Mark P. Lappe, Kelly D. Deck and Brendan P. Eckelman resigned as officers of the Company.
each of Mark P. Lappe, Douglas G. Forsyth, Jon Faiz Kayyem, Kimberly Manhard and Kristiina Vuori resigned from the board of directors of the Company.
each of Mark P. Lappe, Douglas G. Forsyth, Jon Faiz Kayyem, Kimberly Manhard and Kristiina Vuori resigned from the board of directors of the Company.
each of Mark P. Lappe, Kelly D. Deck and Brendan P. Eckelman resigned as officers of the Company.
each of Mark P. Lappe, Douglas G. Forsyth, Jon Faiz Kayyem, Kimberly Manhard and Kristiina Vuori resigned from the board of directors of the Company.
each of Mark P. Lappe, Douglas G. Forsyth, Jon Faiz Kayyem, Kimberly Manhard and Kristiina Vuori resigned from the board of directors of the Company.
each of Mark P. Lappe, Kelly D. Deck and Brendan P. Eckelman resigned as officers of the Company.
Tara Smith, Group President – Agency Services of Stewart Information Services Corporation (the “Company”), informed the Company of her decision to resign from her position with the Company.
Ms. Gerold replaces Steven Gargano who served the Company as CFO since 2020.
Mr. Larson will step down from the role of Chief Financial Officer effective on or about August 5, 2024
Ms. Paláu-Hernández replaces Barry Bruno pursuant to the previously disclosed Cooperation Agreement
On May 29, 2024, Jeryl Hilleman notified the Board of Directors (the “Board”) of Minerva Neurosciences, Inc. (the “Company”) of her intention to resign as a member of the Board, effective August 6, 2024, including from her role as Chair of the Audit Committee of the Board.
On May 24, 2024, Steven Reed provided notice of his resignation as a member of the BLAC Board of Directors (the “ BLAC Board ”) effective immediately
Effective May 31, 2024, Mr. Avraham Gabay’s term as Interim Chief Financial Officer of the Company will conclude
On May 29, 2024, John Stelben notified eHealth, Inc. (the “Company”) of his decision to resign from his position as the Company’s senior vice president, chief financial officer, effective August 30, 2024.
On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.